Nexalin Technology (NXL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.35, -4.08% vs the prior close of $2.45.
- Volume 22.23K shares, 0.0x its 50-day average (light).
- New SEC filings: EFFECT (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
NXL slides 4.1% to $2.35, a 52-week low, 11 down days in a row. Closed at $2.35, -4.08% vs the prior close of $2.45. Day range $2.28–$2.51, opened at $2.44.
NXL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NXL slides 4.1% to $2.35, a 52-week low, 11 down days in a row
- Closed at $2.35, -4.08% vs the prior close of $2.45. Day range $2.28–$2.51, opened at $2.44.
- Volume was 22.23K shares, 0.0x its 50-day average of 1.31M — lighter than usual.
- Price is -62.7% vs its 50-day average ($6.30) and -80.1% vs its 200-day average ($11.83).
- 52-week range $2.10–$50.70; today's close sits at 1% of that range, 95.4% below the 52-week high.
- That makes 11 straight losses.
Oct 15, 2026 — NXL dips 2.4% to $2.45, a 52-week low, 10 down days in a row
- Closed at $2.45, -2.39% vs the prior close of $2.51. Day range $2.10–$2.59, opened at $2.38.
- Volume was 33.00K shares, 0.0x its 50-day average of 1.31M — lighter than usual.
- Price is -62.1% vs its 50-day average ($6.46) and -79.4% vs its 200-day average ($11.90).
- 52-week range $2.10–$50.70; today's close sits at 1% of that range, 95.2% below the 52-week high.
- That makes 10 straight losses.
Oct 14, 2026 — NXL slides 4.9% to $2.51, a 52-week low, 9 down days in a row
- Closed at $2.51, -4.92% vs the prior close of $2.64. Day range $2.38–$2.71, opened at $2.71.
- Volume was 42.50K shares, 0.0x its 50-day average of 1.31M — lighter than usual.
- Price is -62.0% vs its 50-day average ($6.61) and -79.1% vs its 200-day average ($11.98).
- 52-week range $2.38–$50.70; today's close sits at 0% of that range, 95.0% below the 52-week high.
- That makes 9 straight losses.
Oct 13, 2026 — NXL slides 21.4% to $2.64, a 52-week low, 8 down days in a row
- Closed at $2.64, -21.43% vs the prior close of $3.36. Day range $2.53–$3.38, opened at $3.26.
- Volume was 95.80K shares, 0.1x its 50-day average of 1.31M — lighter than usual.
- Price is -61.1% vs its 50-day average ($6.78) and -78.1% vs its 200-day average ($12.06).
- 52-week range $2.53–$50.70; today's close sits at 0% of that range, 94.8% below the 52-week high.
- That makes 8 straight losses.
Oct 12, 2026 — NXL slides 7.4% to $3.36, a 52-week low, 7 down days in a row
- Closed at $3.36, -7.44% vs the prior close of $3.63. Day range $3.32–$3.76, opened at $3.63.
- Volume was 75.20K shares, 0.1x its 50-day average of 1.30M — lighter than usual.
- Price is -51.6% vs its 50-day average ($6.95) and -72.4% vs its 200-day average ($12.15).
- 52-week range $3.32–$50.70; today's close sits at 0% of that range, 93.4% below the 52-week high.
- That makes 7 straight losses.
Oct 9, 2026 — NXL slides 11.7% to $3.63, a 52-week low, 6 down days in a row
- Closed at $3.63, -11.68% vs the prior close of $4.11. Day range $3.50–$3.95, opened at $3.95.
- Volume was 68.00K shares, 0.1x its 50-day average of 1.30M — lighter than usual.
- Price is -48.7% vs its 50-day average ($7.08) and -70.4% vs its 200-day average ($12.24).
- 52-week range $3.50–$50.70; today's close sits at 0% of that range, 92.8% below the 52-week high.
- That makes 6 straight losses.
Oct 8, 2026 — NXL slides 4.9% to $4.11, a 52-week low, 5 down days in a row
- Closed at $4.11, -4.86% vs the prior close of $4.32. Day range $3.97–$4.34, opened at $4.25.
- Volume was 427.50K shares, 0.3x its 50-day average of 1.29M — lighter than usual.
- Price is -43.0% vs its 50-day average ($7.21) and -66.7% vs its 200-day average ($12.34).
- 52-week range $3.97–$60.00; today's close sits at 0% of that range, 93.1% below the 52-week high.
- That makes 5 straight losses.
Oct 7, 2026 — NXL slides 4.0% to $4.32, 4 down days in a row
- Closed at $4.32, -4.00% vs the prior close of $4.50. Day range $4.31–$4.76, opened at $4.38.
- Volume was 90.90K shares, 0.1x its 50-day average of 1.29M — lighter than usual.
- Price is -41.2% vs its 50-day average ($7.35) and -65.3% vs its 200-day average ($12.45).
- 52-week range $4.00–$60.00; today's close sits at 1% of that range, 92.8% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — NXL slides 17.1% to $4.50, 3 down days in a row
- Closed at $4.50, -17.13% vs the prior close of $5.43. Day range $4.50–$5.56, opened at $5.23.
- Volume was 107.80K shares, 0.1x its 50-day average of 1.29M — lighter than usual.
- Price is -39.7% vs its 50-day average ($7.46) and -64.1% vs its 200-day average ($12.55).
- 52-week range $4.00–$60.00; today's close sits at 1% of that range, 92.5% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — NXL slides 5.2% to $5.43
- Closed at $5.43, -5.24% vs the prior close of $5.73. Day range $5.12–$6.30, opened at $5.38.
- Volume was 326.40K shares, 0.3x its 50-day average of 1.28M — lighter than usual.
- Price is -28.9% vs its 50-day average ($7.64) and -57.1% vs its 200-day average ($12.64).
- 52-week range $4.00–$60.00; today's close sits at 3% of that range, 91.0% below the 52-week high.
Oct 2, 2026 — NXL slides 24.1% to $5.73
- Closed at $5.73, -24.11% vs the prior close of $7.55. Day range $5.15–$5.95, opened at $5.63.
- Volume was 1.37M shares, 1.1x its 50-day average of 1.26M.
- Price is -26.7% vs its 50-day average ($7.82) and -55.0% vs its 200-day average ($12.74).
- 52-week range $4.00–$60.00; today's close sits at 3% of that range, 90.4% below the 52-week high.
NXL latest news & SEC filings
Every SEC filing by or about NXL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Oct 8, 2026 · Form S-1/A — S-1/A filing
S-1/A filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Sep 22, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 3, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 3, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 27, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 27, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Aug 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Aug 20, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Things to know before you trade NXL
- How much it moves: over the last 20 sessions the average daily move was 11.27% (largest 76.4%). That is a volatile stock.
- Liquidity: about 3.26M shares (≈$7.65M) trade per day on average.
- 52-week position: $2.35 vs a range of $2.10–$50.70 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:30 on Aug 31, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 1, 2026; 8-K Oct 1, 2026; 8-K Sep 28, 2026.
- Share count: 22.04M shares outstanding (Aug 10, 2026), +26.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Electromedical & Electrotherapeutic Apparatus.
NXL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.44 | 2.51 | 2.28 | 2.35 | 22.23K |
| Oct 15, 2026 | 2.38 | 2.59 | 2.10 | 2.45 | 33.00K |
| Oct 14, 2026 | 2.71 | 2.71 | 2.38 | 2.51 | 42.50K |
| Oct 13, 2026 | 3.26 | 3.38 | 2.53 | 2.64 | 95.80K |
| Oct 12, 2026 | 3.63 | 3.76 | 3.32 | 3.36 | 75.20K |
| Oct 9, 2026 | 3.95 | 3.95 | 3.50 | 3.63 | 68.00K |
| Oct 8, 2026 | 4.25 | 4.34 | 3.97 | 4.11 | 427.50K |
| Oct 7, 2026 | 4.38 | 4.76 | 4.31 | 4.32 | 90.90K |
| Oct 6, 2026 | 5.23 | 5.56 | 4.50 | 4.50 | 107.80K |
| Oct 5, 2026 | 5.38 | 6.30 | 5.12 | 5.43 | 326.40K |
| Oct 2, 2026 | 5.63 | 5.95 | 5.15 | 5.73 | 1.37M |
| Oct 1, 2026 | 8.80 | 10.98 | 6.80 | 7.55 | 62.34M |
| Sep 30, 2026 | 4.48 | 4.50 | 4.10 | 4.28 | 7.10K |
| Sep 29, 2026 | 4.60 | 5.31 | 4.35 | 4.35 | 64.70K |
| Sep 28, 2026 | 4.50 | 4.53 | 4.10 | 4.27 | 5.70K |
| Sep 25, 2026 | 4.39 | 4.39 | 4.39 | 4.39 | 2.20K |
| Sep 24, 2026 | 4.96 | 5.02 | 4.30 | 4.36 | 10.20K |
| Sep 23, 2026 | 4.61 | 5.09 | 4.61 | 4.81 | 7.00K |
| Sep 22, 2026 | 4.40 | 4.63 | 4.31 | 4.63 | 13.30K |
| Sep 21, 2026 | 4.80 | 5.14 | 4.00 | 4.27 | 12.10K |
About Nexalin Technology
Nexalin Technology (NXL) is listed on the Nasdaq and classified by the SEC under “Electromedical & Electrotherapeutic Apparatus”. Its business address is in HOUSTON, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1527352.
NXL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ben Hu | Director | Dec 23, 2025 |
| Alan Kazden | Director | Dec 23, 2025 |
| David Owens | Chief Medical Officer | Dec 23, 2025 |
| Mark White | CEO | Dec 23, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David Owens | Chief Medical Officer | Dec 23, 2025 |
| Carolyn Hamby Shelton | Sr. VP - Quality - Regulatory | Dec 23, 2025 |
| Fleet Justin Van | CFO | Dec 23, 2025 |
| Mark White | CEO | Dec 23, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
NXL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $301.65K | $-8.22M | -0.50 | $-4.96M |
| Dec 31, 2024 | $168.72K | $-7.61M | -0.83 | $-3.94M |
| Dec 31, 2023 | $110.75K | $-4.65M | -0.63 | $-3.84M |
| Dec 31, 2022 | $1.32M | $-1.70M | -0.30 | $-2.22M |
| Dec 31, 2021 | $144.06K | $-6.08M | — | $-1.08M |
Latest balance sheet: total assets $3.00M, total liabilities $1.48M, cash $1.00M (as of Jun 30, 2026).
NXL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)Integer (ITGR)TransMedics (TMDX)Axogen (AXGN)LivaNova (LIVN)Conmed (CNMD)Ceribell (CBLL)InMode (INMD)Electromed (ELMD)Hyperfine (HYPR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NXL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.